Joseph Rubin
Impact in
Papers in
- Co-authors
- Larry K. KvolsCharles G. MoertelMichael J. O’ConnellGloria M. PetersenÞorvarður R. HálfdánarsonKari G. RabeRichard G. HahnAllan J. Schutt
- Journals
- Journal of Clinical Oncology (12 papers)Cancer (11 papers)Mayo Clinic Proceedings (4 papers)Circulation (3 papers)Annals of Oncology (3 papers)
- Partner nations
- United StatesSingaporeMalaysia
In The Last Decade
Joseph Rubin
97 papers receiving 8.2k citations
Hit Papers
Peers
Comparison fields: 5 of 145
- Neurology 3.2k
- Oncology 5.6k
- Epidemiology 4.3k
- Pathology and Forensic Medicine 757
- Hepatology 331
Countries citing papers authored by Joseph Rubin
This map shows the geographic impact of Joseph Rubin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joseph Rubin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joseph Rubin more than expected).
Fields of papers citing papers by Joseph Rubin
This network shows the impact of papers produced by Joseph Rubin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joseph Rubin. The network helps show where Joseph Rubin may publish in the future.
Co-authors
The 25 scholars most cited alongside Joseph Rubin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 84 | |
| 2 | 2010 | 330 | |
| 3 | 2009 | 2 | |
| 4 | 2007 | 10 | |
| 5 | 2007 | 34 | |
| 6 | 2006 | 22 | |
| 7 | 2005 | 23 | |
| 8 | 2005 | 128 | |
| 9 | 2005 | 35 | |
| 10 | 2003 | 0 | |
| 11 | 2003 | 12 | |
| 12 | 2002 | 11 | |
| 13 | 2001 | 86 | |
| 14 | 2001 | 90 | |
| 15 | 1999 | 3 | |
| 16 | 1998 | 39 | |
| 17 | 1997 | 220 | |
| 18 | Treatment of neuroendocrine carcinomas with combined etoposide and cisplatin. Evidence of major therapeutic activity in the anaplastic variants of these neoplasms Hit paper breakdown → | 1991 | 610 |
| 19 | 1990 | 7 | |
| 20 | VP-16-213 chemotherapy for advanced squamous cell carcinoma and adenocarcinoma of the lung. | 1978 | 42 |
About Joseph Rubin
Joseph Rubin is a scholar working on Oncology, Neurology, Epidemiology, Pulmonary and Respiratory Medicine and Pathology and Forensic Medicine, having authored 98 papers that have together received 8.6k indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (34 papers), Neuroblastoma Research and Treatments (33 papers), Lung Cancer Research Studies (24 papers), Colorectal Cancer Treatments and Studies (14 papers), Cancer therapeutics and mechanisms (13 papers), Cancer Treatment and Pharmacology (12 papers), Management of metastatic bone disease (6 papers) and Virus-based gene therapy research (5 papers). The work is most often cited by research in Neurology (3.2k citations), Oncology (5.6k citations), Epidemiology (4.3k citations), Pathology and Forensic Medicine (757 citations) and Hepatology (331 citations). Joseph Rubin has collaborated with scholars based in United States, Singapore and Malaysia. Frequent co-authors include Larry K. Kvols, Charles G. Moertel, Michael J. O’Connell, Gloria M. Petersen, Þorvarður R. Hálfdánarson, Kari G. Rabe, Richard G. Hahn, Allan J. Schutt, David M. Nagorney and Charles Erlichman. Their work appears in journals such as Journal of Clinical Oncology, Cancer, Mayo Clinic Proceedings, Circulation and Annals of Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.